V Valov, J Palmer, M Czech,
A Savova… - Biotechnology & …, 2012 - Taylor & Francis
The aim of this study was to assess the long-term cost-effectiveness of biphasic insulin
aspart 30 versus human premix insulin in patients with type 2 diabetes from a third-party …